Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values 100% of the latter at up to $1.25 billion. The consideration includes $925 million in upfront cash payment and an additional payment of up to $300m based […]
Dutch health technology company Royal Philips has signed an all-cash deal worth $635 million to acquire Capsule Technologies, a portfolio company of Francisco Partners. Based in Massachusetts, Capsule Technologies caters to hospitals and healthcare organizations with medical device integration (MDI) and data technologies. Established in 1997, the company is said to serve more than 2,800 […]
Continue reading …The Asian Development Bank (ADB) has agreed to provide a loan of up to €30 million ($37 million) to Jointown Pharmaceutical Group for expanding pharmaceutical distribution facilities in the China (PRC). The loan will be used towards the construction and expansion of Jointown Pharmaceutical’s pharma distribution facilities in Haikou, Tangshan, and Nanjing. The three facilities […]
Continue reading …Teleflex, a Pennsylvania-based healthcare supplies and services provider, has agreed to acquire hemostatic devices manufacturer Z-Medica, in a deal worth up to $525 million. Based in Connecticut, Z-Medica is a portfolio company of Linden Capital Partners. The company is engaged in developing and commercializing hemorrhage control products. Its three main hemostatic device brands are QuikClot, […]
Continue reading …The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool, the Imperial College London, and the University of Edinburgh to handle the coronavirus outbreak from the government’s rapid response call. This investment in Urgent Public Health Research is necessary to understand COVID-19 as well as its impact on the human […]
Continue reading …behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects the ‘instant triage’ to enable an expedited diagnosis of novel coronavirus cases and ensure resources are properly allocated. According to behold.ai, its red dot algorithm was trained […]
Continue reading …RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial. The RECOVERY clinical trial, which has enrolled the first patients, will test the effects of potential drug treatments for COVID-19 patients admitted to hospitals. The objective of the clinical […]
Continue reading …A new COVID-19 Genomics UK Consortium has been created with support from the UK government to map how the novel coronavirus spreads and behaves by using whole-genome sequencing. The University of Liverpool is the newest member to join the consortium which is said to include the UK’s leading clinicians and scientists. The consortium backed by […]
Continue reading …Thermo Fisher acquisition of Qiagen : US life sciences company Thermo Fisher Scientific has agreed to acquire Qiagen, a Netherlands-based provider of molecular diagnostics and sample preparation technologies in an all-cash deal worth around $11.5 billion. The deal includes the assumption of nearly Qiagen’s $1.4 billion of net debt by the US firm. Thermo Fisher […]
Continue reading …